Clinical trials
Triple Negative Breast Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
94 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 11 |
| 2018 | 8 |
| 2019 | 9 |
| 2020 | 9 |
| 2021 | 6 |
| 2022 | 12 |
| 2023 | 2 |
| 2024 | 11 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Recruiting | 22 |
| Terminated | 20 |
| Active, not recruiting | 17 |
| Unknown status | 4 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 7 |
| Merck Sharp & Dohme LLC | 6 |
| AstraZeneca | 4 |
| Gilead Sciences | 4 |
| Novartis Pharmaceuticals | 4 |
| Queen Mary University of London | 4 |
| Royal Marsden NHS Foundation Trust | 4 |
| Cancer Research UK | 3 |
| Exelixis | 3 |
| Institute of Cancer Research, United Kingdom | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 94 |
| Carcinoma, Non-Small-Cell Lung | 32 |
| Breast Neoplasms | 27 |
| Ovarian Neoplasms | 18 |
| Stomach Neoplasms | 18 |
| Squamous Cell Carcinoma of Head and Neck | 16 |
| Neoplasms | 13 |
| Carcinoma, Renal Cell | 11 |
| Melanoma | 11 |
| Neoplasm Metastasis | 11 |
Trials
Showing 1 to 25 of 94. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.